Article

Trend of clinical trials of new drugs for rare diseases in China in recent 10 years

2023-01-20

Abstract excerpt

<title>Abstract</title> <p>Background<bold>: </bold>Rare disease is a general term for a disease that affects a small number of people but be recognized as a global public health priority. Governments worldwide are paying more and more attention to the academical research and drug investment of rare diseases. The conduct of rare disease clinical trials is still difficult, despite the promotion of government polic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 38224f5b-1c39-581a-9d42-d48a11f1d324
DOI: 10.21203/rs.3.rs-2474262/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Trend of clinical trials of new drugs for rare diseases in China in recent 10 yearsDOI 10.21203/rs.3.rs-2474262/v1Read

Rare Diseases Clinical Trials Toolbox - Public resources and main considerations to set up a clinical trial on medicinal products for humans in EuropeSemantic proximity Read

Application of observational research methods to real-world studies for rare disease drugs: a scoping review protocolSemantic proximity Read

Current Situation of Clinical Trials of Drugs for Children's Indications in ChinaSemantic proximity Read

Characteristics and data reporting of rare disease clinical trials: Getting better but still room for improvementSemantic proximity Read

The Urgent Need to Empower Rare Disease Organizations in China: An Interview-Based StudySemantic proximity Read

Nationwide Comprehensive Epidemiological Study of Rare Diseases in Japan Using a Health Insurance Claims DatabaseSemantic proximity Read

A questionnaire-based study to comprehensively assess the status quo of rare disease patients in ChinaSemantic proximity Read

Spectrum and epidemiology of rare diseases in a Chinese natural population of 14.31 million residents, 2012–2023Semantic proximity Read

Quantifying hope: An EU perspective of rare disease therapeutic space and market dynamicsSemantic proximity Read

Analysis of Patient Access to Orphan Drugs in TurkeySemantic proximity Read

Rare Disease Curative Care Expenditure- Financing Scheme-Health Provider- Beneficiary Group Analysis — An Empirical Study in Sichuan Province, ChinaSemantic proximity Read

Rare diseases in China: analysis of 2014–2015 hospitalization summary reports for 281 rare diseases from 96 tertiary hospitalsSemantic proximity Read